• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促黄体生成素(LH)与泌乳素释放型垂体瘤:LH细胞系可能的恶性转化

Luteinizing hormone (LH) and prolactin-releasing pituitary tumor: possible malignant transformation of the LH cell line.

作者信息

Spertini F, Deruaz J P, Perentes E, Pelet B, Gomez F

出版信息

J Clin Endocrinol Metab. 1986 May;62(5):849-54. doi: 10.1210/jcem-62-5-849.

DOI:10.1210/jcem-62-5-849
PMID:3514650
Abstract

A pituitary tumor was diagnosed in a prepubertal 13-yr-old girl, who had elevated plasma LH (58 mIU/ml) and PRL (93 ng/ml) levels; decreased GH, ACTH, and FSH secretion; and diabetes insipidus. After surgery, plasma LH and PRL declined, but not to normal levels. Conventional external radiotherapy to the pituitary was immediately followed by a decrease in LH to prepubertal values (0.7 mIU/ml), while PRL levels became normal only after a long course of bromocriptine therapy. The pituitary tumor was composed of two distinct cell types: small polygonal cells, which were PRL positive by immunohistochemistry, and clusters of pleomorphic large frequently mitotic polynucleated cells, which were LH positive, some of them also being positive for the alpha-subunit or beta LH but not for beta FSH. Four years after surgery and radiotherapy, the patient deteriorated neurologically. Computed tomographic scan showed widespread frontal and periventricular tumor, which had the histological features of a poorly differentiated carcinoma. No PRL, LH, or alpha- or beta-subunits were detectable on immunocytochemistry. While the PRL-positive cells of the pituitary tumor displayed the histological and clinical features of PRL adenomas, the morphological characteristics of LH cells and the sharp decline of plasma LH levels after radiotherapy were suggestive of malignant transformation. In this context, the later brain tumor could have been the result of subependymal spread of the pituitary tumor after it lost its hormone-secreting capacity.

摘要

一名13岁青春期前女孩被诊断出患有垂体瘤,其血浆促黄体生成素(LH)水平升高(58 mIU/ml),催乳素(PRL)水平升高(93 ng/ml);生长激素、促肾上腺皮质激素和促卵泡激素分泌减少;并患有尿崩症。手术后,血浆LH和PRL下降,但未降至正常水平。垂体接受常规外照射放疗后,LH立即降至青春期前水平(0.7 mIU/ml),而PRL水平仅在长期服用溴隐亭治疗后才恢复正常。垂体瘤由两种不同的细胞类型组成:小的多边形细胞,免疫组化显示PRL阳性;以及多形性大的、频繁有丝分裂的多核细胞簇,LH阳性,其中一些α亚基或β-LH也呈阳性,但β-FSH呈阴性。手术和放疗四年后,患者神经功能恶化。计算机断层扫描显示广泛的额叶和脑室周围肿瘤,具有低分化癌的组织学特征。免疫细胞化学检测未发现PRL、LH或α或β亚基。虽然垂体瘤中PRL阳性细胞表现出PRL腺瘤的组织学和临床特征,但LH细胞的形态特征以及放疗后血浆LH水平的急剧下降提示发生了恶性转化。在这种情况下,后来的脑肿瘤可能是垂体瘤失去激素分泌能力后经室管膜下播散的结果。

相似文献

1
Luteinizing hormone (LH) and prolactin-releasing pituitary tumor: possible malignant transformation of the LH cell line.促黄体生成素(LH)与泌乳素释放型垂体瘤:LH细胞系可能的恶性转化
J Clin Endocrinol Metab. 1986 May;62(5):849-54. doi: 10.1210/jcem-62-5-849.
2
The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.促黄体生成素释放激素(LHRH)激动剂[D-色氨酸6-脯氨酸9-乙基]LHRH在一名分泌促黄体生成素(LH)的垂体肿瘤患者中升高而非降低了LH和α亚基水平。
J Clin Endocrinol Metab. 1984 Feb;58(2):313-9. doi: 10.1210/jcem-58-2-313.
3
[Growth hormone, prolactin, LH and FSH secretion in tissue culture of pituitary adenomas (author's transl)].垂体腺瘤组织培养中生长激素、催乳素、促黄体生成素及促卵泡生成素的分泌(作者译)
No Shinkei Geka. 1977 Oct;5(11):1135-41.
4
Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.促性腺激素和α亚基对糖蛋白激素分泌型垂体瘤患者长期给予促性腺激素释放激素类似物的反应。
J Clin Endocrinol Metab. 1989 Jan;68(1):81-6. doi: 10.1210/jcem-68-1-81.
5
A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.一例分泌促甲状腺激素和催乳素的人垂体腺瘤:免疫组织化学、生物化学及细胞培养研究
J Clin Endocrinol Metab. 1984 Nov;59(5):817-24. doi: 10.1210/jcem-59-5-817.
6
Gonadotroph cell adenomas of the pituitary.垂体促性腺激素细胞腺瘤
Endocr Rev. 1985 Fall;6(4):552-63. doi: 10.1210/edrv-6-4-552.
7
Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies.促黄体生成素分泌型垂体瘤:生物合成特征及临床研究。
J Clin Endocrinol Metab. 1987 Mar;64(3):536-42. doi: 10.1210/jcem-64-3-536.
8
Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture.促性腺激素细胞腺瘤在体内和体外培养时激素分泌行为的比较。
J Clin Endocrinol Metab. 1985 Dec;61(6):1061-5. doi: 10.1210/jcem-61-6-1061.
9
Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.溴隐亭降低垂体促卵泡激素腺瘤中促卵泡激素(FSH)的分泌
J Clin Endocrinol Metab. 1984 Dec;59(6):1220-3. doi: 10.1210/jcem-59-6-1220.
10
Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone.通过促黄体生成素β亚基对促甲状腺激素释放激素的反应来鉴定临床无功能腺瘤男性患者中的促性腺激素腺瘤。
J Clin Endocrinol Metab. 1993 Nov;77(5):1352-5. doi: 10.1210/jcem.77.5.8077332.

引用本文的文献

1
Clinical review: Pituitary carcinoma: difficult diagnosis and treatment.临床综述:垂体癌:诊断和治疗困难。
J Clin Endocrinol Metab. 2011 Dec;96(12):3649-60. doi: 10.1210/jc.2011-2031. Epub 2011 Sep 28.
2
Non-functioning pituitary carcinoma.无功能性垂体癌
Pituitary. 2004;7(3):149-156. doi: 10.1007/s11102-005-3411-3.